Continuous 5-Fluorouracil Infusion and Alpha Interferon in Advanced Cancers: A Report of Initial Treatment Results
- 1 April 1991
- journal article
- clinical trial
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 301 (4) , 246-249
- https://doi.org/10.1097/00000441-199104000-00003
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study.Journal of Clinical Oncology, 1989
- Continuous systemic 5‐fluorouracil infusion in advanced colorectal cancer: Results in 91 patientsJournal of Surgical Oncology, 1989
- Continuous 5-Fluorouracil Infusion in Advanced Gastric CarcinomaAmerican Journal of Clinical Oncology, 1988
- Continuous 5-Fluorouracil (5FU) Infusion in Carcinoma of the Pancreas: A Phase II StudyThe Lancet Healthy Longevity, 1988
- Continuous 5-fluorouracil infusion in refractory carcinoma of the breastBreast Cancer Research and Treatment, 1987
- Long‐term ambulatory treatment of metastatic colorectal adenocarcinoma by continuous intravenous infusion of 5‐fluorouracilJournal of Surgical Oncology, 1985
- Differential action of six human interferons against two human carcinomas growing in nude miceInternational Journal of Cancer, 1985
- Combined effect of 5-fluorouracil and interferon on experimental liver metastases of rat colon carcinomaZeitschrift für Krebsforschung und Klinische Onkologie, 1985
- Cytolytic activity of interferon‐gamma and its synergism with 5‐fluorouracilInternational Journal of Cancer, 1984
- Interferon potentiates cytotoxic effects of 5-fluorouracil on cell proliferation of established human cell lines originating from neoplastic tissuesCancer Letters, 1983